Description

Caberlin 0.25 Cabergoline: Safe Prolactin Control

 

Formulated with cabergoline 0.25mg, Caberlin 0.25 is an ergot-derived dopamine D2-receptor agonist. As a prescription-only medicine (POM), it is licensed for the treatment of hyperprolactinaemia (abnormally high prolactin levels) in adults.

It is bioequivalent to Dostinex, the UK reference brand for cabergoline.

Feature	Caberlin 0.25	Dostinex
Active Ingredient	Cabergoline	Cabergoline
Strength	0.25mg	0.5mg
Drug Class	Ergot-derived dopamine agonist	Ergot-derived dopamine agonist
Prescription Status	POM	POM
Manufacturer	Sun Pharmaceutical Industries Ltd	Pfizer

This is completely normal as they contain the same active ingredient

Composition

Active Ingredient

Cabergoline 0.25 mg (dopamine agonist)

Available Variant

Caberlin 0.5 mg

Manufacturer

Sun Pharmaceutical Industries Limited.

Expiry

Month/Year – indicative; check actual pack

Mechanism of Action

Cabergoline binds to D2 dopamine receptors on lactotroph cells (prolactin-producing cells) in the pituitary gland. This reduces prolactin secretion directly. When prolactin levels fall, symptoms of hyperprolactinaemia gradually improve.

Clinical Uses

Caberlin 0.25 is indicated for:

• Hyperprolactinaemia caused by a pituitary adenoma (benign pituitary tumour) or idiopathic (unknown) origin
• Irregular or absent menstrual cycles caused by excess prolactin
• Prolactin-related infertility in men and women
• Unwanted breast milk secretion (galactorrhoea)
• Clinically indicated lactation suppression

Safety Information

Category	Side Effect	Details
Common Side Effects	Nausea	Discuss with your prescriber if persistent or troublesome
	Dizziness	Discuss with your prescriber if persistent or troublesome
	Headache	Discuss with your prescriber if persistent or troublesome
	Fatigue	Discuss with your prescriber if persistent or troublesome
	Mild stomach discomfort	Discuss with your prescriber if persistent or troublesome
Serious Side Effects (seek urgent medical attention)	Severe hypotension (low blood pressure)	Seek urgent medical attention immediately
	Hallucinations	Seek urgent medical attention immediately
	Cardiac valvulopathy symptoms — breathlessness	May indicate a heart valve problem — seek urgent attention
	Cardiac valvulopathy symptoms — chest discomfort	May indicate a heart valve problem — seek urgent attention
	Severe allergic reaction — rash	Seek emergency medical attention without delay
	Severe allergic reaction — facial swelling	Seek emergency medical attention without delay
	Severe allergic reaction — breathing difficulty	Seek emergency medical attention without delay

Safety Advice

Liver

Use with caution in liver disease. Dose adjustment and routine monitoring may be required during long-term treatment.

Kidney

Generally tolerated in mild to moderate renal impairment. Severe kidney disease requires specialist supervision.

Alcohol

Avoid alcohol whilst taking Caberlin 0.25. Because alcohol can lower blood pressure and impair balance, the risk of dizziness and low blood pressure is heightened when alcohol is consumed alongside this medicine.

Driving

Caberlin 0.25 may cause dizziness and sudden drowsiness. Until you know how this medicine affects your ability to drive safely, driving must be avoided.

Pregnancy

Use only under direct medical supervision. Inform your doctor immediately if you become pregnant during treatment.

Breastfeeding

Not recommended. Cabergoline suppresses lactation and is not compatible with breastfeeding. Consult your doctor for alternatives.

Accessing Treatment Responsibly

You must obtain Caberlin 0.25 with a valid prescription from a registered health professional, as it is a prescription-only medicine (POM). Always access treatment through a regulated pharmacy. Never purchase from unregulated online sources.

Frequently Asked Questions

Q: What is the use of Caberlin 0.25 mg Tablet?

A: Caberlin 0.25mg is prescribed for hyperprolactinaemia, a condition causing excess prolactin. It helps manage irregular periods, infertility, unwanted breast milk production, and hormonal imbalance in adults.

Q: Is Caberlin 0.25 a steroid?

A: No. Caberlin 0.25 is not a steroid. It contains cabergoline, an ergot-derived dopamine agonist. Prolactin secretion from the pituitary gland is reduced by cabergoline.

Conclusion

Caberlin 0.25 (cabergoline 0.25mg) is a prescription-only dopamine agonist for hyperprolactinaemia. It requires regular medical monitoring. Always follow your prescriber’s guidance and attend all clinical appointments.

References

• NHS: www.nhs.uk
• MHRA: www.gov.uk/mhra

Medical Disclaimer

Caberlin 0.25 is a prescription-only medicine and must be used only under the supervision of a qualified prescriber. This article is for information purposes only and does not replace professional medical advice. Always consult a registered healthcare professional before starting or changing any treatment.